Sciencast Management LP Purchases 54,765 Shares of Option Care Health, Inc. $OPCH

Key Points

• Sciencast Management LP increased its holdings in Option Care Health, Inc. by 148.5% in Q1, resulting in ownership of 91,632 shares valued at approximately $3.2 million.
• Company earnings per share for the last quarter were $0.41, outperforming analysts' expectations of $0.40, alongside a revenue increase of 15.4% year-over-year to $1.42 billion.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Option Care Health, with eight analysts rating it a Buy and target prices reaching up to $38.00.

Sciencast Management LP raised its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 148.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 91,632 shares of the company's stock after acquiring an additional 54,765 shares during the quarter. Sciencast Management LP owned about 0.06% of Option Care Health worth $3,203,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in OPCH. Durable Capital Partners LP acquired a new stake in Option Care Health in the first quarter valued at approximately $122,905,000. Nuveen LLC acquired a new stake in Option Care Health in the first quarter valued at approximately $70,965,000. Allspring Global Investments Holdings LLC lifted its stake in shares of Option Care Health by 6,525,926.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock worth $52,459,000 after buying an additional 1,500,963 shares during the last quarter. Voloridge Investment Management LLC acquired a new stake in shares of Option Care Health in the fourth quarter worth $27,428,000. Finally, Fuller & Thaler Asset Management Inc. lifted its stake in shares of Option Care Health by 30.8% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock worth $146,947,000 after buying an additional 989,048 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of analyst reports. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.89 during trading hours on Friday, hitting $28.48. 1,626,043 shares of the company traded hands, compared to its average volume of 1,842,623. The stock has a market capitalization of $4.62 billion, a price-to-earnings ratio of 22.78, a P/E/G ratio of 1.79 and a beta of 0.82. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The firm has a 50-day moving average of $29.09 and a 200 day moving average of $31.43. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction on Wednesday, August 20th. The shares were purchased at an average price of $27.15 per share, with a total value of $977,400.00. Following the acquisition, the director directly owned 375,390 shares of the company's stock, valued at $10,191,838.50. This represents a 10.61% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction on Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the acquisition, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 59,411 shares of company stock valued at $1,627,576 in the last 90 days. 0.64% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.